Phase II evaluation of neoadjuvant chemotherapy and debulking followed by intraperitoneal chemotherapy in women with stage III and IV epithelial ovarian, fallopian tube or primary peritoneal cancer: Southwest Oncology Group Study S0009
- 31 March 2009
- journal article
- research article
- Published by Elsevier BV in Gynecologic Oncology
- Vol. 112 (3), 444-449
- https://doi.org/10.1016/j.ygyno.2008.10.028
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Delaying the primary surgical effort for advanced ovarian cancer: A systematic review of neoadjuvant chemotherapy and interval cytoreductionGynecologic Oncology, 2007
- Intraperitoneal carboplatin-based chemotherapy for epithelial ovarian cancerGynecologic Oncology, 2005
- Neoadjuvant chemotherapy for advanced ovarian cancerInternational Journal of Gynecologic Cancer, 1996
- Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian CancerThe New England Journal of Medicine, 1996
- Neoadjuvant Chemotherapy for Advanced Ovarian CancerGynecologic Oncology, 1994
- The influence of cytoreductive surgery on recurrence-free interval and survival in small-volume Stage III epithelial ovarian cancer: A gynecologic oncology group studyGynecologic Oncology, 1992
- Neoadjuvant chemotherapy and interval debulking for advanced epithelial ovarian cancerGynecologic Oncology, 1991
- Neoadjuvant chemotherapy in stage X ovarian carcinomaGynecologic Oncology, 1990
- Intraperitoneal carboplatin in the treatment of minimal residual ovarian cancerGynecologic Oncology, 1990
- The treatment of advanced ovarian carcinoma (I): Clinical variables associated with prognosisGynecologic Oncology, 1988